News &
Media
Neurotech International: NWR Virtual Healthcare Conference with Dr Thomas Duthy
View MoreNeurotech International Ltd Extends Rett Syndrome Study With Novel Cannabinoid Drug
View MoreNeurotech extends clinical trials for the $US2bn Rett Syndrome market
View MoreNeurotech International extends NTI164 Rett Syndrome trial to 52 weeks
View MoreNeurotech International receives HREC approval for cerebral palsy treatment trial
View MoreNeurotech International: Quarterly Investor Conference Call – Q4 FY23
View MoreListen to the audio here | Time: 22.10
Neurotech International: Quarterly Investor Conference Call with Dr Thomas Duthy for the period ending 31 March 2023
View MoreListen to the audio here | Time: 17.45
Small Caps Inverview: Neurotech International advances novel treatment for autism spectrum disorder
View MoreWatch the presentation here | Time: 22:15
NWR Virtual Healthcare Conference Presentation: Neurotech International Investor Presentation
View MoreWatch the presentation here | Time: 28:10